New Key Statistics Module, Z-Score and F-Score
NAS:CLRB Key Ratios
Market Cap $ M | 74.03 |
Enterprise Value $ M | 50.73 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 7.65 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -3.08 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 53.50 |
5-y EBITDA Growth Rate % | 39.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.20 |
EV-to-EBITDA | -1.21 |
PEG | -- |
Shares Outstanding M | 35.85 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 2.54 |
Current Ratio | 2.54 |
ROA % (ttm) | -260.44 |
ROE % (ttm) | -1,391.18 |
ROIC % (ttm) | -705.28 |
Dividend Yield % | -- |
Altman Z-Score | -- |
CLRB Number of Guru Trades
CLRB Volume of Guru Trades
Gurus Latest Trades with NAS:CLRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLRB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cellectar Biosciences Inc Insider Transactions
No Available Data
News about NAS:CLRB
Total 0- 1